Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure I have ever seen a CEO on the OTC 100% follow through on everything he has set out to do. Bodes very well for the future endeavors and stock price here.
Still loading!
XCRT - Awesome news - CEO continues to keep his word. Very rare!
Just saw the news - Beautiful! Mike continues to keep his word and follow through on every single thing he has stated.
Exactly - shares for acquisitions and Reg A for funding - great news!
And the dumbest person on ihub by far.
So embarrassing!!!
Nice close!
Yep - saw the exact same thing
Old info - check the filings - he is not part of XCRT in any way!!!
LOL - the Pig guy has absolutely nothing to do with XCRT. He has no involvement, has no shares - not mentioned once in the filings.
100% confirmed!
Big bidders. Flush these sellers out for good.
Holding up amazingly well in this crappy market. Thin as ever and primed to breakout once buying returns. Looking for lots more good news and OTCQB submission shortly.
Definitely a Nasdaq Board of Directors already!
It's coming - nice day today - get the small time flippers out down here. So much news to look forward to!
Here she is - so impressive - major credentials, connections and responsibilities -
https://newjerseyglobe.com/governor/governor-unveils-deal-with-irish-company-applegreen-for-new-glen-rock-headquarters/
Governor unveils deal with Irish company Applegreen for new Glen Rock headquarters
Murphy, delegation spent morning pitching New Jersey to a number of Irish businesses
By Joey Fox, April 25 2022 8:09 am
DUBLIN – Gov. Phil Murphy announced today that Applegreen, a Dublin-based company that operates highway service plazas in Europe and the United States, has chosen Glen Rock as the new location for its U.S. headquarters. The governor said that the relocation will immediately come with an investment of $125 million and create 100 new jobs, with another 800 jobs projected to come in future years.
“I cannot wait to see Applegreen settle into its new American home in New Jersey,” Murphy said. “The lease has already been signed and we’re ready to roll out the welcome mat.”
Murphy added that he was specifically proud to have worked with Applegreen given the company’s focus on green energy and electrical vehicle infrastructure.
“It’s not just any company,” he said. “It’s Irish, and it’s completely consistent with the things that we care about.”
According to Wesley Mathews, the CEO of the privately funded economic development organization Choose NJ, the deal with Applegreen has been three years in the making.
As for why Glen Rock, Choose NJ chief business development officer Cathy Scangarella said that Applegreen’s representatives simply liked Bergen County and the amenities it offers.
Applegreen already operates 21 stations in New Jersey, all of which are soon to be redeveloped, and the company has hundreds more around the United States. One of the New Jersey stations that will be redone, the Brookdale South parkway station in Bloomfield, has drawn controversy for a plan to give retail space to Chick-Fil-A, a fast food restaurant with a history of anti-LGBTQ stances; Murphy had no comment on the plans the last time he was asked.
Prior to today’s announcement, Murphy and delegates from New Jersey’s economic development operation held a roundtable with representatives of ten Irish companies that might be interested in following Applegreen to the Garden State.
“When people ask me to describe our state and say, ‘give us the words we should associate with you,’ I think there are two: talent and location,” Murphy said, noting New Jersey’s diversity, concentration of universities, and frequent nonstop flights to Ireland.
Murphy and his team acknowledged that the state is not necessarily the cheapest to run a business in – something New Jersey Republicans have pilloried for years – but argued that the state’s strong education system and incentive packages make the investment worthwhile.
“Our mantra is good value for money,” Murphy said. “Some states have as their bumper sticker, ‘No taxes, good weather.’ Our bumper sticker is, ‘The #1 state in America to raise a family.’ And that does not come free of charge.”
Murphy’s three-day trip to Ireland has economic, diplomatic, and cultural elements; earlier today, the governor met with U.S. Ambassador to Ireland Claire Cronin, and he will make a trip to his ancestral homeland of Cork tomorrow.
Everywhere the governor has gone, he has emphasized the connections between Ireland and New Jersey, which has one of the largest Irish-American populations of any state.
“You look in the mirror in New Jersey and you see Ireland,” he said at today’s roundtable. “And you look in the mirror in Ireland, and I think you see New Jersey.”
Here she is - so impressive - major credentials, connections and responsibilities -
https://newjerseyglobe.com/governor/governor-unveils-deal-with-irish-company-applegreen-for-new-glen-rock-headquarters/
Governor unveils deal with Irish company Applegreen for new Glen Rock headquarters
Murphy, delegation spent morning pitching New Jersey to a number of Irish businesses
By Joey Fox, April 25 2022 8:09 am
DUBLIN – Gov. Phil Murphy announced today that Applegreen, a Dublin-based company that operates highway service plazas in Europe and the United States, has chosen Glen Rock as the new location for its U.S. headquarters. The governor said that the relocation will immediately come with an investment of $125 million and create 100 new jobs, with another 800 jobs projected to come in future years.
“I cannot wait to see Applegreen settle into its new American home in New Jersey,” Murphy said. “The lease has already been signed and we’re ready to roll out the welcome mat.”
Murphy added that he was specifically proud to have worked with Applegreen given the company’s focus on green energy and electrical vehicle infrastructure.
“It’s not just any company,” he said. “It’s Irish, and it’s completely consistent with the things that we care about.”
According to Wesley Mathews, the CEO of the privately funded economic development organization Choose NJ, the deal with Applegreen has been three years in the making.
As for why Glen Rock, Choose NJ chief business development officer Cathy Scangarella said that Applegreen’s representatives simply liked Bergen County and the amenities it offers.
Applegreen already operates 21 stations in New Jersey, all of which are soon to be redeveloped, and the company has hundreds more around the United States. One of the New Jersey stations that will be redone, the Brookdale South parkway station in Bloomfield, has drawn controversy for a plan to give retail space to Chick-Fil-A, a fast food restaurant with a history of anti-LGBTQ stances; Murphy had no comment on the plans the last time he was asked.
Prior to today’s announcement, Murphy and delegates from New Jersey’s economic development operation held a roundtable with representatives of ten Irish companies that might be interested in following Applegreen to the Garden State.
“When people ask me to describe our state and say, ‘give us the words we should associate with you,’ I think there are two: talent and location,” Murphy said, noting New Jersey’s diversity, concentration of universities, and frequent nonstop flights to Ireland.
Murphy and his team acknowledged that the state is not necessarily the cheapest to run a business in – something New Jersey Republicans have pilloried for years – but argued that the state’s strong education system and incentive packages make the investment worthwhile.
“Our mantra is good value for money,” Murphy said. “Some states have as their bumper sticker, ‘No taxes, good weather.’ Our bumper sticker is, ‘The #1 state in America to raise a family.’ And that does not come free of charge.”
Murphy’s three-day trip to Ireland has economic, diplomatic, and cultural elements; earlier today, the governor met with U.S. Ambassador to Ireland Claire Cronin, and he will make a trip to his ancestral homeland of Cork tomorrow.
Everywhere the governor has gone, he has emphasized the connections between Ireland and New Jersey, which has one of the largest Irish-American populations of any state.
“You look in the mirror in New Jersey and you see Ireland,” he said at today’s roundtable. “And you look in the mirror in Ireland, and I think you see New Jersey.”
Yes sir - massive!
XCRT - just added more!
Added!
XCRT - Huge is right - incredible connections and she will be working with XCRT to locate suitable partners in the Pharma arena to further develop their very large patent portfolio.
Just keeps getting better and better!
Huge is right - incredible connections and she will be working with XCRT to locate suitable partners in the Pharma arena to further develop their very large patent portfolio.
Just keeps getting better and better!
Sad lonely old man. Nothing better to do I guess. Embarrassing.
Exactly!!!
People have no idea or they would be scooping up all of the shares down here they can. Going to be a Monster play!!!
They will catch on very soon imo.
OTCQB in the very near term!
Incredible - going to be one of the biggest OTC gainers once the market recovers.
Amazing article out -
https://www.smallcapvoice.com/xcelerating-the-business-of-global-healthcare/
Xcelerating the Business of Global Healthcare
Xcelerating the Business of Global Healthcare
In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, there are villages across this planet that have experienced decades of limited-to-no access to simple medical equipment, qualified healthcare professionals or sanitary treatment facilities.
In Africa, this is a major problem.
According to the World Health Organization, there’s currently one doctor for every 20,000 patients in Tanzania. In Sierra Leone, there are a total of 3 physicians per every 100,000. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
That’s where Xcelerate, Inc. is stepping up to the charge.
Socially Responsible, XCRT ‘Xcelerates’ The Growth And Impact by Delivering Of World-Class Healthcare Solutions.
Xcelerate Inc (OTCMKTS: XCRT) takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of AfiyaSasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
For some, a regular check-up is often out of the question. But thanks to recent advancements in technology, Xcelerate is able to fill this void from a medical standpoint, helping patients overcome major hurdles preventing patients from maintaining their basic healthcare needs.
Xcelerate has assembled an internationally renowned team of clinicians, thought leaders, Nobel Prize Winners, Ivy League Graduates, engineers, and business professionals, who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
The company’s CEO, Mr. Michael O’Shea, is himself a forensic accountant with over 35 years of expertise in international investigations, corporate due diligence, and crisis management as well as functioning as a court-appointed receiver of distressed businesses including medical practices.
AdviNOW Is Proof That Unrealized Applications In Non-Medical Society Could Revolutionize The Way We Practice Medicine.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
The systems are further set up to work and facilitate use in conjunction with robotic surgery, as well as the case for augmented and virtual reality systems for use in medical procedures.
Tanzania To Be The First Country To Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
Kilimanjaro Christian Medical Centre (KCMC)
NSK Hospitals
Arusha Lutheran Medical Center (ALMC)
Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million potential patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested, and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q3 2022, and that revenue will begin before the end of 2022.
Globally, Equity Funding For Digital Health Hit All-Time High Of $26.5 Billion In 2020
Given the recent demand for telemedicine and how it has impacted the entire industry, it’s essential to know and understand that the bulk of Xcelerate’s business actually comes from its acquisition and licensing of patented intellectual properties.
The company’s team of engineers, physicians and thought-leaders come together as a united front to identify, acquire, and develop existing non-medical technologies for use in a controlled, clinical-care setting. This often includes improvements to already popular technologies – or the modification of said technologies for use in the medical field.
By securing patents for existing, non-medical devices and their unrealized application in the medical realm could bode well on account of advanced engineering and medicine.
Reintroducing cutting-edge products as purposeful medical technologies could open new doors to future breakthroughs in the medical industry. Likewise, it could provide doctors with an alternative of retrofitting surgical equipment for use and implementation, should the situation call for one.
Xcelerate considers itself a clinical / medtech incubator, acquiring innovative startups and nurturing their ideas through ongoing research and development. And while the company is interested in taking these ideas to market.
While the company services several different verticals and has created multiple revenue streams, its primary source of revenue is generated through licensing fees.
Reliance on standard, ground-up research and development is also reduced – and also eliminated – through this approach.
Xcelerate’s first acquisition was a patent license for material initially developed for use in the heat wicking of gun barrels. Since then, this concept has evolved into a series of patents that apply this same material to high heat-generating surgical instruments.
After obtaining exclusive rights to this advanced metal alloy technology, a layer of coating was implemented in the final development of a high-precision surgical drill. By reducing the friction and buildup of heat in the equipment itself, the company created a design for a breakthrough product with an improved tolerance to vibration and a low propensity towards overheating.
The Future Appears Bright For MedTech’s Rising Star
Xcelerate operates with next to zero overhead expenses and currently holds no debt for which it is to be held accountable. Within the next few months, it plans to uplist from the OTC Pink Markets to the OTCQB, with its eyes set on the Nasdaq in the near future.
The Company has submitted its annual audited financial reporting to the U.S. Securities and Exchange Commission (SEC) for years 2019 and 2020 – and now, 2021.
The Company received S.E.C. conformation for a Regulation-A Tier-2 offering, with a timely goal to raise enough capital to rapidly expand upon these projects
XCRT - Amazing article out -
https://www.smallcapvoice.com/xcelerating-the-business-of-global-healthcare/
Xcelerating the Business of Global Healthcare
Xcelerating the Business of Global Healthcare
In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, there are villages across this planet that have experienced decades of limited-to-no access to simple medical equipment, qualified healthcare professionals or sanitary treatment facilities.
In Africa, this is a major problem.
According to the World Health Organization, there’s currently one doctor for every 20,000 patients in Tanzania. In Sierra Leone, there are a total of 3 physicians per every 100,000. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
That’s where Xcelerate, Inc. is stepping up to the charge.
Socially Responsible, XCRT ‘Xcelerates’ The Growth And Impact by Delivering Of World-Class Healthcare Solutions.
Xcelerate Inc (OTCMKTS: XCRT) takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of AfiyaSasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
For some, a regular check-up is often out of the question. But thanks to recent advancements in technology, Xcelerate is able to fill this void from a medical standpoint, helping patients overcome major hurdles preventing patients from maintaining their basic healthcare needs.
Xcelerate has assembled an internationally renowned team of clinicians, thought leaders, Nobel Prize Winners, Ivy League Graduates, engineers, and business professionals, who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
The company’s CEO, Mr. Michael O’Shea, is himself a forensic accountant with over 35 years of expertise in international investigations, corporate due diligence, and crisis management as well as functioning as a court-appointed receiver of distressed businesses including medical practices.
AdviNOW Is Proof That Unrealized Applications In Non-Medical Society Could Revolutionize The Way We Practice Medicine.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
The systems are further set up to work and facilitate use in conjunction with robotic surgery, as well as the case for augmented and virtual reality systems for use in medical procedures.
Tanzania To Be The First Country To Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
Kilimanjaro Christian Medical Centre (KCMC)
NSK Hospitals
Arusha Lutheran Medical Center (ALMC)
Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million potential patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested, and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q3 2022, and that revenue will begin before the end of 2022.
Globally, Equity Funding For Digital Health Hit All-Time High Of $26.5 Billion In 2020
Given the recent demand for telemedicine and how it has impacted the entire industry, it’s essential to know and understand that the bulk of Xcelerate’s business actually comes from its acquisition and licensing of patented intellectual properties.
The company’s team of engineers, physicians and thought-leaders come together as a united front to identify, acquire, and develop existing non-medical technologies for use in a controlled, clinical-care setting. This often includes improvements to already popular technologies – or the modification of said technologies for use in the medical field.
By securing patents for existing, non-medical devices and their unrealized application in the medical realm could bode well on account of advanced engineering and medicine.
Reintroducing cutting-edge products as purposeful medical technologies could open new doors to future breakthroughs in the medical industry. Likewise, it could provide doctors with an alternative of retrofitting surgical equipment for use and implementation, should the situation call for one.
Xcelerate considers itself a clinical / medtech incubator, acquiring innovative startups and nurturing their ideas through ongoing research and development. And while the company is interested in taking these ideas to market.
While the company services several different verticals and has created multiple revenue streams, its primary source of revenue is generated through licensing fees.
Reliance on standard, ground-up research and development is also reduced – and also eliminated – through this approach.
Xcelerate’s first acquisition was a patent license for material initially developed for use in the heat wicking of gun barrels. Since then, this concept has evolved into a series of patents that apply this same material to high heat-generating surgical instruments.
After obtaining exclusive rights to this advanced metal alloy technology, a layer of coating was implemented in the final development of a high-precision surgical drill. By reducing the friction and buildup of heat in the equipment itself, the company created a design for a breakthrough product with an improved tolerance to vibration and a low propensity towards overheating.
The Future Appears Bright For MedTech’s Rising Star
Xcelerate operates with next to zero overhead expenses and currently holds no debt for which it is to be held accountable. Within the next few months, it plans to uplist from the OTC Pink Markets to the OTCQB, with its eyes set on the Nasdaq in the near future.
The Company has submitted its annual audited financial reporting to the U.S. Securities and Exchange Commission (SEC) for years 2019 and 2020 – and now, 2021.
The Company received S.E.C. conformation for a Regulation-A Tier-2 offering, with a timely goal to raise enough capital to rapidly expand upon these projects
XCRT - Amazing article out -
https://www.smallcapvoice.com/xcelerating-the-business-of-global-healthcare/
Xcelerating the Business of Global Healthcare
Xcelerating the Business of Global Healthcare
In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, there are villages across this planet that have experienced decades of limited-to-no access to simple medical equipment, qualified healthcare professionals or sanitary treatment facilities.
In Africa, this is a major problem.
According to the World Health Organization, there’s currently one doctor for every 20,000 patients in Tanzania. In Sierra Leone, there are a total of 3 physicians per every 100,000. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
That’s where Xcelerate, Inc. is stepping up to the charge.
Socially Responsible, XCRT ‘Xcelerates’ The Growth And Impact by Delivering Of World-Class Healthcare Solutions.
Xcelerate Inc (OTCMKTS: XCRT) takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of AfiyaSasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
For some, a regular check-up is often out of the question. But thanks to recent advancements in technology, Xcelerate is able to fill this void from a medical standpoint, helping patients overcome major hurdles preventing patients from maintaining their basic healthcare needs.
Xcelerate has assembled an internationally renowned team of clinicians, thought leaders, Nobel Prize Winners, Ivy League Graduates, engineers, and business professionals, who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
The company’s CEO, Mr. Michael O’Shea, is himself a forensic accountant with over 35 years of expertise in international investigations, corporate due diligence, and crisis management as well as functioning as a court-appointed receiver of distressed businesses including medical practices.
AdviNOW Is Proof That Unrealized Applications In Non-Medical Society Could Revolutionize The Way We Practice Medicine.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
The systems are further set up to work and facilitate use in conjunction with robotic surgery, as well as the case for augmented and virtual reality systems for use in medical procedures.
Tanzania To Be The First Country To Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
Kilimanjaro Christian Medical Centre (KCMC)
NSK Hospitals
Arusha Lutheran Medical Center (ALMC)
Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million potential patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested, and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q3 2022, and that revenue will begin before the end of 2022.
Globally, Equity Funding For Digital Health Hit All-Time High Of $26.5 Billion In 2020
Given the recent demand for telemedicine and how it has impacted the entire industry, it’s essential to know and understand that the bulk of Xcelerate’s business actually comes from its acquisition and licensing of patented intellectual properties.
The company’s team of engineers, physicians and thought-leaders come together as a united front to identify, acquire, and develop existing non-medical technologies for use in a controlled, clinical-care setting. This often includes improvements to already popular technologies – or the modification of said technologies for use in the medical field.
By securing patents for existing, non-medical devices and their unrealized application in the medical realm could bode well on account of advanced engineering and medicine.
Reintroducing cutting-edge products as purposeful medical technologies could open new doors to future breakthroughs in the medical industry. Likewise, it could provide doctors with an alternative of retrofitting surgical equipment for use and implementation, should the situation call for one.
Xcelerate considers itself a clinical / medtech incubator, acquiring innovative startups and nurturing their ideas through ongoing research and development. And while the company is interested in taking these ideas to market.
While the company services several different verticals and has created multiple revenue streams, its primary source of revenue is generated through licensing fees.
Reliance on standard, ground-up research and development is also reduced – and also eliminated – through this approach.
Xcelerate’s first acquisition was a patent license for material initially developed for use in the heat wicking of gun barrels. Since then, this concept has evolved into a series of patents that apply this same material to high heat-generating surgical instruments.
After obtaining exclusive rights to this advanced metal alloy technology, a layer of coating was implemented in the final development of a high-precision surgical drill. By reducing the friction and buildup of heat in the equipment itself, the company created a design for a breakthrough product with an improved tolerance to vibration and a low propensity towards overheating.
The Future Appears Bright For MedTech’s Rising Star
Xcelerate operates with next to zero overhead expenses and currently holds no debt for which it is to be held accountable. Within the next few months, it plans to uplist from the OTC Pink Markets to the OTCQB, with its eyes set on the Nasdaq in the near future.
The Company has submitted its annual audited financial reporting to the U.S. Securities and Exchange Commission (SEC) for years 2019 and 2020 – and now, 2021.
The Company received S.E.C. conformation for a Regulation-A Tier-2 offering, with a timely goal to raise enough capital to rapidly expand upon these projects
XCRT - Amazing article out -
https://www.smallcapvoice.com/xcelerating-the-business-of-global-healthcare/
Xcelerating the Business of Global Healthcare
Xcelerating the Business of Global Healthcare
In March 2020, telemedicine became essential not only in the U.S. but to the entire world, as we faced the uncertainty of a global coronavirus pandemic. Almost overnight, technology became paramount in healthcare and telehealth and telemedicine programs became top level advertising. While we’ve been relatively fortunate with this transition, believe it or not, there are villages across this planet that have experienced decades of limited-to-no access to simple medical equipment, qualified healthcare professionals or sanitary treatment facilities.
In Africa, this is a major problem.
According to the World Health Organization, there’s currently one doctor for every 20,000 patients in Tanzania. In Sierra Leone, there are a total of 3 physicians per every 100,000. And according to GlobalVoices.org, “ At the peak of COVID-19 in 2020, the Central African Republic, a country of about 5 million people, had just 3 ventilators.”
That’s where Xcelerate, Inc. is stepping up to the charge.
Socially Responsible, XCRT ‘Xcelerates’ The Growth And Impact by Delivering Of World-Class Healthcare Solutions.
Xcelerate Inc (OTCMKTS: XCRT) takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of AfiyaSasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
For some, a regular check-up is often out of the question. But thanks to recent advancements in technology, Xcelerate is able to fill this void from a medical standpoint, helping patients overcome major hurdles preventing patients from maintaining their basic healthcare needs.
Xcelerate has assembled an internationally renowned team of clinicians, thought leaders, Nobel Prize Winners, Ivy League Graduates, engineers, and business professionals, who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
The company’s CEO, Mr. Michael O’Shea, is himself a forensic accountant with over 35 years of expertise in international investigations, corporate due diligence, and crisis management as well as functioning as a court-appointed receiver of distressed businesses including medical practices.
AdviNOW Is Proof That Unrealized Applications In Non-Medical Society Could Revolutionize The Way We Practice Medicine.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
The systems are further set up to work and facilitate use in conjunction with robotic surgery, as well as the case for augmented and virtual reality systems for use in medical procedures.
Tanzania To Be The First Country To Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
Kilimanjaro Christian Medical Centre (KCMC)
NSK Hospitals
Arusha Lutheran Medical Center (ALMC)
Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million potential patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested, and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q3 2022, and that revenue will begin before the end of 2022.
Globally, Equity Funding For Digital Health Hit All-Time High Of $26.5 Billion In 2020
Given the recent demand for telemedicine and how it has impacted the entire industry, it’s essential to know and understand that the bulk of Xcelerate’s business actually comes from its acquisition and licensing of patented intellectual properties.
The company’s team of engineers, physicians and thought-leaders come together as a united front to identify, acquire, and develop existing non-medical technologies for use in a controlled, clinical-care setting. This often includes improvements to already popular technologies – or the modification of said technologies for use in the medical field.
By securing patents for existing, non-medical devices and their unrealized application in the medical realm could bode well on account of advanced engineering and medicine.
Reintroducing cutting-edge products as purposeful medical technologies could open new doors to future breakthroughs in the medical industry. Likewise, it could provide doctors with an alternative of retrofitting surgical equipment for use and implementation, should the situation call for one.
Xcelerate considers itself a clinical / medtech incubator, acquiring innovative startups and nurturing their ideas through ongoing research and development. And while the company is interested in taking these ideas to market.
While the company services several different verticals and has created multiple revenue streams, its primary source of revenue is generated through licensing fees.
Reliance on standard, ground-up research and development is also reduced – and also eliminated – through this approach.
Xcelerate’s first acquisition was a patent license for material initially developed for use in the heat wicking of gun barrels. Since then, this concept has evolved into a series of patents that apply this same material to high heat-generating surgical instruments.
After obtaining exclusive rights to this advanced metal alloy technology, a layer of coating was implemented in the final development of a high-precision surgical drill. By reducing the friction and buildup of heat in the equipment itself, the company created a design for a breakthrough product with an improved tolerance to vibration and a low propensity towards overheating.
The Future Appears Bright For MedTech’s Rising Star
Xcelerate operates with next to zero overhead expenses and currently holds no debt for which it is to be held accountable. Within the next few months, it plans to uplist from the OTC Pink Markets to the OTCQB, with its eyes set on the Nasdaq in the near future.
The Company has submitted its annual audited financial reporting to the U.S. Securities and Exchange Commission (SEC) for years 2019 and 2020 – and now, 2021.
The Company received S.E.C. conformation for a Regulation-A Tier-2 offering, with a timely goal to raise enough capital to rapidly expand upon these projects
Lol. Amazing what a little dd will do. No longer a shell!!!
Otcmarkets will update but XCRT as of right now is no longer a shell company!!!
Yes - it is. $150,000 of his own money because he believes so much in the company and its' projects and what they can do to greatly benefit the medical community and improve on healthcare throughout the world. All Directors and Board Members have 1 common goal and will accomplish everything they set out to do IMO.
And we will benefit as the stock price soars!
Lol. If you read the filings you can see the CEO Mike has put $150,000 of his own money in the company as well.
But of course why do any DD.
Very impressive and a huge sign of confidence in the company and its future!!!
Holding up great!!!
Loving the consistent accumulation here - powder keg once the market comes back!
Will be the best on the OTC imo!
Great day. Will be there very soon.
Nice!!! Bargain basement prices right now.
It's his price prediction for end of month.
Beauty - building a powerhouse!
Astounding, informative, incredible post - sums up why the longs are here and continue to add. Have no doubt with the beyond reproach CEO, directors and board members XCRT will uplist in the very near future. So much has been accomplished already and so much more is in the works and yet to be announced.
Company is light years ahead of where we were when the stock hit .15.